Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara 44121, Italy.
Department of Health Sciences, University of Piemonte Orientale, Novara 28100, Italy.
Am J Hum Genet. 2021 Aug 5;108(8):1512-1525. doi: 10.1016/j.ajhg.2021.06.012. Epub 2021 Jul 8.
The pathogenic significance of nucleotide variants commonly relies on nucleotide position within the gene, with exonic changes generally attributed to quantitative or qualitative alteration of protein biosynthesis, secretion, activity, or clearance. However, these changes may exert pleiotropic effects on both protein biology and mRNA splicing due to the overlapping of the amino acid and splicing codes, thus shaping the disease phenotypes. Here, we focused on hemophilia A, in which the definition of F8 variants' causative role and association to bleeding phenotypes is crucial for proper classification, genetic counseling, and management of affected individuals. We extensively characterized a large panel of hemophilia A-causing variants (n = 30) within F8 exon 19 by combining and comparing in silico and recombinant expression analyses. We identified exonic variants with pleiotropic effects and dissected the altered protein features of all missense changes. Importantly, results from multiple prediction algorithms provided qualitative results, while recombinant assays allowed us to correctly infer the likely phenotype severity for 90% of variants. Molecular characterization of pathogenic variants was also instrumental for the development of tailored correction approaches to rescue splicing affecting variants or missense changes impairing protein folding. A single engineered U1snRNA rescued mRNA splicing of nine different variants and the use of a chaperone-like drug resulted in improved factor VIII protein secretion for four missense variants. Overall, dissection of the molecular mechanisms of a large panel of HA variants allowed precise classification of HA-affected individuals and favored the development of personalized therapeutic approaches.
核苷酸变异的致病意义通常依赖于基因内的核苷酸位置,外显子变化通常归因于蛋白质生物合成、分泌、活性或清除的定量或定性改变。然而,由于氨基酸和剪接码的重叠,这些变化可能对蛋白质生物学和 mRNA 剪接产生多效性影响,从而塑造疾病表型。在这里,我们专注于血友病 A,其中 F8 变异的致病作用和与出血表型的关联对于正确分类、遗传咨询和受影响个体的管理至关重要。我们通过组合和比较计算机模拟和重组表达分析,对 F8 外显子 19 中的一大组血友病 A 致病变异体 (n = 30) 进行了广泛的特征描述。我们确定了具有多效性影响的外显子变异体,并剖析了所有错义变化的改变蛋白特征。重要的是,来自多种预测算法的结果提供了定性结果,而重组分析允许我们正确推断 90%变异体的可能表型严重程度。对致病变异体的分子特征进行分析,对于开发针对剪接影响变异体或影响蛋白折叠的错义变化的定制纠正方法也很重要。单个工程化 U1snRNA 可纠正 9 种不同变异体的 mRNA 剪接,而使用类似伴侣的药物可改善 4 种错义变异体的因子 VIII 蛋白分泌。总体而言,对大量 HA 变异体的分子机制进行剖析,可精确分类受 HA 影响的个体,并有利于开发个性化的治疗方法。